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Abstract: The gastrointestinal microbiome plays a critical role in aiding the host in 
maintaining homeostasis.  Probiotic bacteria can aid the microbiota in maintenance of 
homeostasis by performing a multitude of functions such as modulating the immune 
system, maintaining the intestinal epithelium, and inhibiting pathogens.  A probiotic 
organism is “-a live microorganism that, when administered in adequate amounts, confers 
a health benefit to the host.”  Several species from the genus of Lactobacillus are known 
probiotics.Lactobacilli have been used to manufacture fermented food products, have 
been found to be involved in the decay of plant matter, and are members of the oral, 
gastrointestinal and vaginal microbiomes.  A body of evidence that probiotics, including 
certain strains of Lactobacillus, may be able to positively influence the gut-brain axis is 
emerging.Microtusochrogaster, the prairie vole, is a highly social animal and an excellent 
model for the studying the effect of environmental factors on behavior.  Males that have 
not pair-bonded exhibit a high degree of interest in unfamiliar voles,but when exposed to 
mercury a shift in this behavior occurs and the animals develop an aversion to strangers.  
It is possible that administration of probiotics, such as lactobacilli, may be able to reverse 
this altered behavior.  The probiotic potential of lactobacilli has been shown to be strain 
specific and there is a need to characterize the molecular mechanisms involved in 
probiosis.  To understand the underlying mechanics by which probiotic strains of 
Lactobacillus could potentially reverse the effectof mercury exposure on prairie vole 
behavior,it is necessary to understand the genes involved and their function at a 
molecularlevel.  To lay the foundation for future studies regarding these mechanisms, the 
genomes of threeLactobacillusstrains previously isolated fromthe gastrointestinal tract of 
prairie voles, and tested in vitro forprobiotic characteristics,were sequenced using the Ion 
Torrent PGM®.  Potential homologues of genes involved in probiotic action were 
identified and described in this study. 
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CHAPTER I 
 
 
INTRODUCTION 
 
The gastrointestinal microbiota plays an important role in the normal functioning of the host and 
has been shown to be involved in key processes such as break down of dietary 
components,immune system modulation, regulation of fat storage, intestinal epithelial integrity, 
and protection of the host by exclusion of pathogens [1].  Some members of the human gut 
microbiota have been selected as probiotics.  Selection is based on their health benefits, safety, 
stability and ability to survive within the human host [2, 3].  A probiotic is “-a live 
microorganism that, when administered in adequate amounts, confers a health benefit to the host” 
[4].  The probiotic effects of lactobacilli have been studied extensively and many of these studies 
demonstrated that probiotics can be used to promote health while somestudies have had mixed 
results.  These conflicting results point to the factthat a better understanding of the mechanisms 
by which probiotics function at the molecular level is needed[2].Application of comparative 
genomics to genomes of probiotic strains could provide deeper insight into these mechanisms of 
probiosis.  In recent years, the emergence of new sequencing technologies has dropped the price 
and amount of time required to sequence a bacterial genome, making it feasible to identify the 
genes that confer probiotic qualities and investigate their molecular functions. 
The genus Lactobacilluswas first proposed in 1901 by Beijerinck based on physiology and 
morphology[5],close to the time whenMetchnikoff suggested that consumption of lactic acid
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bacteria benefits one’s health[6].The genus Lactobacillus is a groupof gram-positive bacteria 
belonging to the family Lactobacillaceae, order Lactobacillales, class Bacillus and phylum 
Firmicutes.  Currently, over 100 species of Lactobacillus have been identified[7], some of which 
are used in food production, others are involved in the decay of plant material, and others are 
members of the microbiotas of the gastrointestinal tract, vaginal flora, or the oral cavity.  
Lactobacilli are non-sporeforming rods with low G+C content genomes, most are microaerophilic 
and catalase negative[5].  Being nutritionally fastidious they require a rich growth medium and 
typically ferment carbohydrates to produce lactic acid as the major end product.  The probiotic 
characteristics of lactobacilli include immunomodulation, inhibition of pathogens and microbe-
microbe interactions, as well asstrengthening of the gut epithelium[2].   
Microtusochrogaster, the prairie vole, is a highly social animal with many communal behaviors 
that are similar to humans making this animal an excellent model for the study of social 
behavior[8].  Curtis et al. have developed M. ochrogaster as an animal model for social behavior 
that could also serve as a model for the behavioral aspects of Autism Spectrum Disorders 
(ASD)[8].  When exposed to mercury chloride in drinking water, non-pair-bonded males develop 
a strong aversion to unfamiliaranimals and prefer to be with familiar animals.  This behavioral 
change was sex specific, affecting only non-pair bonded males and not females or pair bonded 
males.  Additionally, an increase in locomotor activity in response to amphetamine exposure was 
not seen in the non-pair-bonded voles exposed to mercury chloride but was seen in the control 
group and female animals.  Response to amphetamines is mediated via the central dopamine 
pathways implying that exposure to mercury may alter this pathway.   
The gut-brain-axis is the biochemical connection between the gut and the central nervous 
system[9].  There is a growing body of research on the communication between the gut and brain 
and the influence the gut microbiota may have on this communication[10].  It has been 
demonstrated that probiotics can have a positive effect on the gut-brain axis.  Probiotics may be 
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able tonegate the altered social behavior seen in male prairie voles exposed to mercury.  To 
beginthe process of testing this hypothesis Köhleret al.(pers. communication) isolated thirty 
Lactobacillusstrains from the gastrointestinal tract of M. ochrogaster.Lactobacillus strains native 
to the prairie vole intestinewere selected because adaptation to the hostis an important 
prerequisite for an effective probiotic.According to 16SrRNAgene sequencing and Random 
Amplification of Polymorphic (RAPD) DNA fingerprinting all isolated strains were most closely 
related to Lactobacillusjohnsonii. All strains were tested for probiotic characteristics including 
bile resistance, acid tolerance, adherence to intestinal cells (Caco-2 cell line), hydrogen peroxide 
production, and antimicrobial effects, i.e. the inhibition of Candida albicans, Pseudomonas 
aeruginosa, Staphylococcus aureus, and non-pathogenic Escherichia coliK-12. Furthermore, the 
ability to survive in the presence of mercury chloride was tested.  Based on the results of these in 
vitro tests,the genomes ofthree of the isolated vole Lactobacillus strains were selected to be 
sequenced using the Ion Torrent PGMTMnext-generation sequencer (Life Technologies, Carlsbad, 
CA). 
Sequencing of the first human genome was completed in 2003 at a cost of 2.7 billion dollars[11]. 
Today next-generation sequencing allows for massively parallel sequencing, which has made it 
possible to sequence the genome of a person within only a few daysat a dramatically reduced 
cost.  Sanger sequencing is considered first-generation sequencing and next-generation 
sequencing is sometimes broken down into second-generation and third-generation[12].  Second-
generation sequencing requires a clonal amplification step prior to sequencing while third-
generation sequencing is based on single molecule sequencing. The Ion Torrent PGM was 
launched in 2011 and utilizes emulsion PCR to clonally amplifya prepared DNA fragment library 
onto beads that are then loaded into individual sensor wells in a semiconductor chip[13].  During 
the sequencing reaction the chip is flooded with one deoxynucleotidetriphosphate at a time, and 
as they are incorporated a hydrogen ion is released that is detected by an ion-sensitive field-effect 
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transistor. When compared to Roche 454 GS Junior (Roche 454 Life Sciences,Branford, CT) 
andIlluminaMiSeq (Illumina Inc. San Diego, CA) next-generation sequencing systems, the Ion 
Torrent PGM was found to be the least expensive, with the highest throughputand shortest run 
time, but produced the highest number of homopolymers errors[14].  Ion Torrent technology was 
successfully utilized during the early stages of the 2011 German outbreak of 
enterohemorrhagicEscherichia coli O104:H4 to sequence the strain’s genome within three days 
and allow for timely identification of virulence factors as well as tracking of the source [15].  As 
another example, Ion Torrent sequencing has also been used successfully to profile the intestinal 
microbiome in patients who received fecal transplants after Clostridium difficile infections[16].  
In the present study the Ion Torrent PGMTM was utilized to sequence the genomes of three 
Lactobacillus strains isolated from the intestinal tract of M. ochrogaster.  The genomes were 
annotated using Rapid Annotation using Subsystem Technology (RAST)[17] and genes that may 
confer probiotic capabilities were identified.
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
Immunomodulation 
The volume of research concerning thepotential mechanisms by which lactobacilli can modulate 
the immune system is rapidly growing.  A review by Kemang et. al. outlines the mechanisms how 
lactobacilli can alter immune functionssuch as increasing secretory IgA release, stimulating 
antimicrobial compound and mucinproduction,as well as the inhibition of pathogens at the 
gastrointestinal mucosa[18].  The ability of certain strains to promote the release of anti-
inflammatory cytokines is also discussed, as well as the ability of other strains to stimulate the 
proliferation of lymphocytes and increase macrophage activity.  Many studies have reported 
positive effects of lactobacilli on the immune system.  Lactobacillus caseidecreased the severity 
and death rate of mice infected with Salmonella typhimuriumby improving the immune response 
[19, 20].  Bifidobacteriumlactis BB12 initiated the NF-κB and p38 MAPK pathways upon initial 
colonization triggering IL-6 gene expression [21] suggesting this strain could potentially be 
utilized to stimulate the immune system.  It is not known,however, if this strain would induce 
inflammation in immunosuppressed animals or in animals in which antibiotics have altered the 
gut microbiota [22].  Lactobacillus plantarumwas able to stimulate lymphocyte responses in 
immunocompromised and immunocompetent mice despite the fact that the bacteriumwas shown 
to be unable to persist in the gut [23].
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Many probiotic characteristics such as stimulation of anti-inflammatory responses, improvement 
of allergic reactions and resistance to pathogens can be attributed to the ability to modulate 
immune responses [24, 25].  One way lactobacilli may influence immune responses is through 
dendritic cells.  Dendritic cells are antigen presenting cells which play a central role in regulating 
the immune response both systemically and at mucosal sites.  Dendritic cells are found in 
locations that are exposed to the environment including the intestine where they can be found 
interdigitating epithelial cells.  As dendritic cells encounter microbial antigens they undergo 
phenotypic and functional changes that lead to secretion of chemokines and cytokines that 
stimulate the cells of innate and adaptive immunity.  Dendritic cells can stimulate CD4+ T cells (T 
helper) cells to become T helper 1 or T helper 2 cells[26].  Excessive response of T helper 2 cells 
is implicated in atopic allergies[27].Lactobacillus gasseri, L.johnsonii, and L.reuteriexhibited the 
ability to shift cytokine expression in dendritic cells toward T helper 1 differentiation[28].How 
lactobacilli modulate immune responses is strain-specific as seen in a study in which L. 
johnsoniiNCC533 caused a shift toward the expression of IgG1 isotype in immune cell, which is 
associated with IL4 induction of B cells and the T helper 2 response, while L.paracaseicaused a 
shift toward the expression of the IgG2aisotype, which is associated with IFN-γ stimulation of B 
cells and a T helper 1immune response [29]. Additionally, exposure of mouse spleen tissue to L. 
acidophilus ATCC 4356, L.gasseri ATCC 33323, L.rhamnosus LC705, and L.caseiShirota 
resulted in differing levels of T and B cell proliferation that were unique to the individual 
strains[30]. 
Probiotics may also help to negate the negative impact of stress on the immune system.  Mice that 
were stressed due to restriction of food and mobilitythat received L.casei CRL 431exhibited an 
increased level of CD4+ cells in the lamina propria, an increase in IgA-producing cells, an 
increase in secretory IgA in the lumen, and lower levels of IFN-γ when compared to mice that did 
notreceive the L. casei CRL 431 but where subjected to the same stressors[31].  Broiler 
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chickenssubjected to heat stress and given a Lactobacillus-based probiotic showed an improved 
humoral immune response to vaccinations given prior to exposure to heat stress, as well as 
decreased cortisol levels when compared to the control group [32].  In another study regarding the 
ability of probiotics to negate the negative effects of stress on the immune system, 136 university 
students, who were undoubtedly stressed because the study occurred during the period prior to 
final examinations, were given either milk fermented withL.casei DN-114001 (Actimel®)or 
skimmed milk[33]. The study occurred over a six week period and the group that received the 
probiotic milkdrink exhibited an increase in the number of total lymphocytes and CD56+cells.  
Students in the control group exhibited a decrease in lymphocytes and CD56+cells(CD56 is a 
marker for natural killer cells). 
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Pathogen Inhibition 
A favorable influence on the composition of the gut microbiome is an important aspect of 
probiosis in which actions such as inhibition of pathogens through competition for nutrients, 
production of antimicrobial compounds, and competitive exclusion are generally considered,but 
probiotics may also work through synergistic mechanisms with endogenous bacteria [2].  When 
Bacteroidesthetaiotaomicron, a prominent member of the adult microbiome, was introduced into  
germ-free micein the presence of Bifidobacteriumlongum, a minor member of the adult 
microbiome and a probiotic, an expansion in the diversity of polysaccharides degraded by 
B.thetaiotaomicronwas observed[34].Comparison of host epithelial transcriptomes from mono-
colonized and co-colonized mice in this study found that co-colonization resulted in an induction 
of host genes involved in innate immunity while mono-colonization failed to do 
so.Bacteriodesspecies produce a number of oligosaccharides from the breakdown of complex 
carbohydrates.  These oligosaccharides are fermented by lactic acid bacteria which 
thermodynamically favors further metabolism of complex carbohydrates by Bacteriodes[2, 35].  
While probiotic bacteria comprise a small portion of the gastrointestinal microbiota, they play a 
vital role in the support of larger populations within the microbiota helping to strengthen and 
maintain the normal intestinal microbiota and thus act as strong pathogen deterrent.   
Enteric pathogens have been shown to attach to oligosaccharide receptor sites in the intestine. 
There is evidence that probiotic bacteria can utilize the same attachment sites thereby excluding 
pathogens[2].  HT29 cells, a human colorectal cell line, upregulated expression of mucin genes in 
the presence of L.plantarum 299v and when co-incubated with Escherichia coli E2348/69 
decreased the ability of E. coli to adhere to the cell line[36].  A mutant version of 
L.plantarum299v deficient in a mannose-specific adhesin exhibited a marked reduction in the 
ability to decrease E. coli adhesion.  Another study found that biosurfactants produced by L. 
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reuteriRC-14(formerly L. acidophilus RC14) and L.fermentum B54 decreased the ability of the 
uropathogenEnterococcus faecalis1131 to adhere to glass in a parallel-plate flow chamber [37]. 
Lactobacilli also synthesize antimicrobial compounds such as hydrogen peroxide, bacteriocins, 
and lactic acid, all ofwhich can inhibit pathogens [2]. 
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Epithelial Barrier Enhancement 
Another important mechanism by which probiotic bacteria benefit their host is through 
enhancement of the epithelial barrier.  One mode in which lactobacilli may enhance the function 
of the gastrointestinal epithelium is via the production of lactic acid, which is then metabolized to 
butyrate by endogenous bacteria[2, 38].  Butyrate is the preferred energy source for colonic 
epithelial cells [39] and has been shown to play an important role in colonic health.  At low 
butyrate concentrations a decrease in permeability occurs and permeability decreases as butyrate 
concentration increase, however, at very high butyrate concentrations an increase in permeability 
is seen [40].  Another mechanism by which lactobacilli may promote the health of the 
gastrointestinal epithelium is throughincreasing the production of mucin[41].  Mucin genes were 
induced in Caco-2 cells upon exposure toL.salivariusUCC118.  Disruption of a sortase gene 
(srtA) reduced L. salivariusUCC118 adhesion to the Caco-2 cells and resulted in a reduction in 
the expression of mucin genes.  Certain Lactobacillus strains may also protect epithelial tight 
junctions from damage.For example, L.rhamnosusGG reduced the damage to tight junctions 
caused by Escherichia coli O157:H7 in polarized MDCK-I (Madin-Darby canine kidney) and 
T84 (human colonic) cell lines[41]. Additionally,L. rhamnosusGG cells and culture supernatant 
were able to mitigate cytokine-induced apoptosis in cultured mouse colon explantsand in the 
mouse colonic cell line KSRI (kinase suppressor of Ras1 knockout), as well as in HT29 (human 
colonic) cells [42].  While the exact mechanism by which probiotics enhance epithelium barrier 
function is not fully understood, it appears to be an important function of probiotic bacteria such 
as lactobacilli.  
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Probiotics and the Gut-Brain Axis 
The biochemical signaling occurring between the gastrointestinal tract and the nervous system is 
referred to as the gut-brain-axis and it is regulated by both the central and enteric nervous 
systems.  The gut-brain-axis is essential in maintenance of bodily homeostasis and disturbances in 
this system result in alterations in behavior and response to stress [9]. There is growing 
acknowledgement of the bidirectional communication between the gut and brain as well as the 
central role the influence of the gut microbiota might play in this communication [10].  The 
underlying mechanisms of this relationship are not yet fully understood. 
Changes in the composition of the gut microbiota are associated with changes in behavior. 
Berciket al. suggest a direct connection between the gut microbiota and the brain in light of their 
study which found that alteration of the gut microbiota with antimicrobials caused a change in the 
behavior of mice as well as modification in the expression of brain-derived neurotropic factor 
(BDNF) in the hippocampus[43].  These changes reversed with the withdrawal of antimicrobials 
and no such changes were present in germ-free mice that were given antimicrobials.  The central 
nervous system also has profound effects on the composition of the gut microbiome.  In mice that 
were subjected to the social stressor, -‘social disruption,’- a shift in the microbiota was noted, i.e. 
with a decrease in the genus Bacteriodesand an increase in the genus Clostridium[44].  This 
change was most notable immediately after stress exposure.  An increase in the proinflammatory 
cytokine IL-6 and the chemokine MCP-1 (Monocyte Chemoattractant Protein 1) wasalso seen 
after stress exposure.  This increase in IL-6 and MCP-1 was not seen in stressed mice which were 
treated with antibiotics. 
There is also increasing evidence that probiotics including certainLactobacillusstrains may be 
able to influence the gut-brain axis in a positive manner.  When mice were infected with 
Citrobacterrodentium, a Gram-negative bacterium known to cause colitis in mice, they showed 
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symptoms of memory dysfunction upon exposure to acute stress[45].  Administration 
ofL.rhamnosusR0011 and L.helveticusR0052 prevented the memory dysfunction.  A combination 
of L.helveticus R0052 and Bifidobacteriumlongum R0175 reduced anxiety-like behavior in rats 
and in human volunteers it produced beneficial psychological effects in addition to reducing 
serum cortisol levels [46].  Both viable and attenuated L.reuteriATCC 23272 decreased the 
perception of pain caused by colorectal distensionin healthy Sprague-Dawley rats [47].  L. 
acidophilus was found to increase the expression of opioid and cannabinoid receptors in gut 
epithelial cell which may cause an analgesic affect [48].  Children with Irritable Bowel Syndrome 
(IBS), who were given L.rhamnosusGG showed moderate improvement in abdominal pain during 
an eight week randomized control trial [49].  Induced colitis in mice produced anxiety-like 
behavior and also altered the expression of BNDF in the hippocampus[50].  Administration of 
B.longum, a known probiotic, reversed the altered behavior and brain chemistry.  Levels of 
proinflammatory cytokines remained high in the animals given B. longum,indicating that the 
reversal of the anxiety-like behavior in this case was not related to immunomodulation.  In 
another study, administration of L.rhamnosusJB-1 reduced anxiety-like and depression-like 
behaviors, lowered the level ofcorticosterone and altered expression of GABA receptors in mice 
[51].   
There is clear evidence that probiotics can influence the gut microbiome and the gut-brain-axis in 
a positive manner.Probiotics may influence the gut-brain axis via direct interaction with the 
enteric nervous system, by the production of molecules that influence the nervous system or by 
improving epithelial function and restricting toxic metabolites from entering the circulation.  The 
molecular mechanisms by which the microbiome or probioticsinteract with the gut-brain axis, 
however,are not well understood.  The relationship is undoubtedly complex, most likely 
involving multiple signaling pathways. There is a need to understand both how the central 
nervous system of the host can affect the gut microbiome and how the microbiome can in turn 
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affect the central nervous system.  A fuller grasp on how the molecular mechanisms of probiosis 
function will aid in a clearer understanding of this complex relationship.    
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A History of Conflicting Clinical Trials 
Since Metchnikoff first proposed that the long life of Bulgarian peasants was due to the large 
amount of lactic acid bacteria-containing yogurt they consumed, the use of probiotics to promote 
health has steadily increased and now is a multi-billion dollar industry.  Currently probiotics are 
categorized as supplements and are not subject to rigorous evaluation by the US Food and Drug 
Administration (FDA).  For a probiotic product to be marketed for therapeutic use the 
manufacturer must submit an Investigational New Drug Application.  To date there are no 
probiotic products on the market thathave been approved for therapeutic use by the FDA[52].  
Clinical trials on the effectiveness of probiotics to treat various diseases have conflicting results, 
but there is enough compelling evidence to support the use of probiotics to treat and prevent 
disease. 
There is extensive literature regarding the treatment of Inflammatory Bowel Disease (IBD) with 
probiotics, which has yielded mixed results.  IBD is a spectrum of disorders characterized by 
ulceration, inflammation and stenosis of the gastrointestinal tract.  An inability to tolerate 
commensal organisms is thought to play a role in the pathogenesis of IBD.  The immune system 
of the gut is unique in its tolerance of commensal organisms that if found in other parts of the 
body would cause a severe and damaging immune response[53].  Some studies have shown 
probiotic intervention to be highly effective in treatment of IBD patients with pouchitis, an 
inflammation of the pouch created from the small intestine to hold waste after surgical removal of 
the colon.  In a randomized double-blind placebo-controlled trial of forty patients with pouchitis, 
half receivedVSL#3 (4 strains of lactobacilli, 3 strains of bifidobacteria, and 1 strain of 
Streptococcus salivarius subsp. thermophilus) of which only three were reported to show signs of 
relapse, while all twenty in the placebo group had a relapse of pouchitis[54].  Additionally all 
patients had a subsequent relapse after discontinuation of probiotic treatment.  The same probiotic 
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mixture was again shown to be effective in treatment of recurrentpouchitis in a second group of 
patients who underwent surgery for IDB[55] and again in patients which chronic pouchitis[56].  
Not all studies, however, have shown probiotics to be of benefit in the treatment of IBD.  A 
different studyusing VSL#3 resulted in many of the patients discontinuing use due to a lack of 
improvement in their chronic pouchitis[57].Another study also found the use of L.johnsoniiLA1 
ineffective for prevention of Crohn’s disease relapse in patients in remission after surgery[58]. 
Much literature regarding the use of probiotics to treat female urogenital disorders exists, albeit 
with mixed results.Lactobacilli are the predominant member of the vaginal microbiome and low 
levels of Lactobacillus has been associated with bacterial vaginosis[59].  In a randomized control 
trial of 125 premenopausal women diagnosed with bacterial vaginosis, treatment with 
metronidazole in combination with L.rhamnosus GR-1 and L.reuteriRC-14resulted in an 88% 
cure rate while treatment with metronidazole alone resulted in a cure rate of only 40% [60].  A 
randomized control trial comparing the effectiveness of L. acidophilus, acetic acid and a placebo 
in the treatment of bacterial vaginosis in pregnant women found an 88% cure rate in the L. 
acidophilus group, 38% in the acetic acid group, and only 15% in the placebo [61].  As with the 
clinical trials for probiotic treatment of IBD, not all of the studies on treatment of bacterial 
vaginosis with probiotics were successful.  A double-blind placebo-controlled study with 187 
women found that women who were treated intravaginallywith a mixture of freeze-dried L. 
fermentum, L. casei, L. rhamnosus and L. gasseri in addition to receiving clindamycin had an 
improvement rate of only 56% while the placebo group had a cure rate of 63%[62].  A study of L. 
acidophilus NCDO 1748 alone for treatment of bacterial vaginosisresulted in only 7% cure rate 
versus 93% for metronidazole alone[63]. 
It is possible that lactobacilli may provide a bacterial barrier to the pathogens that cause urinary 
tract infection as the number of lactobacilli in women with recurrent urinary tract infections are 
often depleted [64].  However, little success has been seen in clinical trials.In a randomized 
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double-blind placebo-controlled trial, there was no difference in the recurrence of urinary tract 
infections in patients who used L. rhamnosussuppositories compared to the control group [65].  
Another study using L. rhamnosusGG found 39% of women utilizing the probiotic had recurrence 
of urinary tract infections.  Women who were given cranberry-lingonberry juice concentrate had a 
recurrence rate of only 16% while the control group had a recurrence rate of 39%[66].In contrast, 
a recent pilot study of nine women found Lactobacillus crispatus GAI 98332 effective in 
reducing the number of recurrent urinary tract infections [67]. 
Lactobacilli have been shown to be effective in the treatment of gastrointestinal problems such as 
colitis associated with Clostridium difficile infection [68], diarrhea associated with 
antibiotics(often due toC. difficile overgrowth), diarrhea due to infectious diseases and travel 
[69], as well as prevention of necrotizing enterocolitis in preterm neonates [70]. Probiotics may 
also help prevent colorectal cancer.  Administration of the prebiotic, oligofructose-enriched inulin 
(SYN1) with probiotic strains, L.rhamnosusGG (LGG) and Bifidobacteriumlactis Bb12 (BB12) 
increased the number of Bifidobacteriumand Lactobacillus and decreased the number of 
Clostridium perfringens while altering tumor makers favorably in patients with a history of 
colorectal cancer or polyps [71]. 
Much of the evidence from clinical trials for the use of probiotics in the treatment and prevention 
of disease is conflicting, but it must be taken into account that clinical trials depend largely on the 
compliance of the individuals involved and that probiotic qualities are specific to individual 
strains.  The difference among strains is demonstrated by the ability of L.rhamnosusGR-1, which 
was isolated from the female urogenital tract, to colonize the vagina more readily and 
protectagainst urinary tract infections when compared to L.rhamnosusGG, which was isolated 
from the gastrointestinal tract[72].  The genetic difference between strains needs to be taken into 
account when investigating probiotics for disease prevention and treatment.    
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The Genes behind Probiotic Outcomes 
Probiotic bacteria benefit their host though multiple factors such as suppressing the overgrowth of 
harmful bacteria, enhancing epithelial barrier function, and modulation of the immune system 
[2].For a bacterial strain to be effective as a probiotic it must be able to survive the harsh 
conditions of the gastrointestinal tract, including pH levels below 3.0, the presence of bile salts, 
and a constantly moving environment.  The ability to persist in the intestinal tract and provide 
health benefits varies greatly between bacterial strains and depends on the genetic makeup of the 
strain.  Following is a description of genes and molecules that have been characterized in regard 
to their involvement in mechanisms of probiosis.   
 
D-alanylation of Lipoteichoic Acids 
Cell wall composition and the ability to incorporate D-alanine into teichoic acids play an 
important role in the ability of bacteria to survive in the gastrointestinal tract.  The dltABCD 
operon, found in Gram-positive bacteria, encodes four proteins involved in the process of 
addition of D-alanine tolipoteichoic acids (LTA)[73-75].DltAencodes a D-alanyl carrier protein 
ligase, which activates D-alanine with ATP.  DltBencodes a putative transmembrane protein that 
is potentially involved in movement of the activated complex of carrier protein and D-alanine 
across the glycerol phosphate backbone of LTA.  DltC encodes the carrier protein and dltDa 
membrane protein involved in ligation of D-alanine to LTA[73-75].  D-ala ester mutants vary 
widely in phenotype and the relationship of genotype to phenotype is strain specific due to the 
complexity of this operon[73]. 
Inactivation of the dltoperon in L. rhamnosusGG resulted in a 2.4-fold-increased cell length, a 
lowered ability to survive in gastric juice, an increased susceptibility to human beta-defensin-2, 
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and an increased rate of autolysis[73].  This mutant strain also displayed a decreased ability to 
grow in the presence ofcationic peptides such as those produced by the innate immune system.  
This mutant, however, still had the ability to adhere to a human cell line and form a biofilm. The 
cytokine expression in cell lines challenged with the wild-type and the mutant remained similar.  
An in vivo study of anotherdltoperon mutant, generated from aL. reuteristrain exhibited an 
impaired ability to colonize the gastrointestinal tract of Lactobacillus-free mice and a reduced 
ability to form a biofilm layer in the foregut[76].  This mutant also showed evidence of cell wall 
damage when inspected with electron microscopy, as well as a decreased ability to survive under 
acidic conditions and in the presence of the lantibioticnisin.  However,ex vivo testing showed no 
decrease in the mutant’s ability to adhere to foregut epithelium . L. plantarumdltmutants 
produced a decrease in the inflammatory response [77, 78], demonstrating the importance of LTA 
composition in immunomodulation.  The variability of cell wall composition may offer an 
explanation to the conflicting results regarding the ability of Lactobacillus strains to 
regulateimmune responses [78]. 
 
Bile Resistance 
Bile salts contribute to the harsh environment encountered by bacteria in the gastrointestinal tract 
and bile salt hydrolases are common in lactobacilli and bifidobacteria isolated from the intestinal 
tract while uncommon in members of these species isolated from other locations[2].  Conjugated 
bile salt hydrolases have an N-terminal cysteine residue, belong to the chologlycine hydrolase 
family, and are classified as N-terminal nucleophilic hydrolases [79].Several studies have shown 
that bile salt hydrolase genes are expressed inLactobacillusspp.in the gastrointestinal tract as well 
as upon exposure to bile salts during in vitro testing[80-82].  The number of bile salt hydrolase 
genes varies between species of lactobacilli and the reason for variability in the gene copy 
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number remains unknown[83].A lower tolerance to glycine-conjugated bile salts was seen in 
absh-1mutant strainof L.plantarumWCFS1 [84].  Inactivation of two genes encoding for bile salt 
hydrolases in L. acidophilus NCFM, however,resulted in no reduction inbile salt resistance[85].  
In addition no reduction in bile resistance was noted in a mutant strain of L. johnsoniiNCC533 
after a triple knock-out of bile salt hydrolase genes [86]. 
Another mechanism that lactobacilli may use to resist bile is multidrug resistance (MDR) 
transporters.  While MDR transporters are well known for their role in antibiotic resistance, they 
also have been shown to play a role in bacterial bile resistance [2, 87].Three exporter proteins, 
one of which was a MDR transporter, were found to be activated by the presence of bile in 
L.plantarumWCFS1 [88].  Disruption of a multidrug resistance transporter associated with a two-
component response regulator involved in bile tolerance in L. acidophilus NCFM resulted in 
increased sensitivity to bile[89]. 
While it is unclear if the hydrolysis of bile salts is necessary for lactobacilli to survive within the 
gastrointestinal tract, bile salt hydrolysis may benefit the host by lowering of cholesterol.  Bile 
salts are formed from cholesterol and once bile salts are deconjugated by intestinal bacteria, they 
are less soluble and more likely to be excreted.  Lactobacilli are the largest subset of intestinal 
bacteria responsible for bile salt hydrolysis in the murine and chicken intestinal tract [90, 91].In 
vitro testing demonstrates differences among strains in their ability to alter cholesterol 
levels.Ingestion of L. acidophilus RP32 helped to lower serum cholesterol in pigs fed a high 
cholesterol diet while L. acidophilus P47 did not[92].  Both strains were resistant to bile, but only 
strain RP32 was able to remove cholesterol from growth media and lower cholesterol in the 
animal model.L.plantarumwas able to lower cholesterol levels and increase LDL receptor 
expression in rats fed a high fat diet[93].  L.plantarumLP27, isolated from Tibetan kefir, was able 
to lower serum levels of cholesterol, triglycerides, and LDL-C in rats fed a high-cholesterol 
diet[94].  In addition, expression of theNiemann-Pick C1-like 1 (NPC1L1) gene, which encodes a 
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protein involved in absorption of cholesterol, was lower in Caco-2 cells when exposed to L. 
plantarumLP27.It is unclear whether bile salt hydrolases do increase the ability of lactobacilli to 
survive in the gastrointestinal tract, but they may still benefit the host by aiding in the regulation 
of cholesterol levels.  
 
Bacteriocins 
Many lactobacilli produce bacteriocins, a group of anti-microbial peptides, which are targeted at 
closely related organisms and appear to be regulated by population density[2].  Class II 
bacteriocins or non-lantibioticbacteriocins are heat stable, non-modified proteins and are the most 
common type of bacteriocin produced by lactobacilli[95].  The ability to produce bacteriocins has 
traditionally been considered important in the selection of probiotic strains, although there are 
relatively few studies that have clearly demonstrated the role of bacteriocins in gastrointestinal 
tract colonization or an involvement in probiosis[96].   
Bacteriocins have shown some potential to inhibit pathogens such as Listeria 
monocytogenes.Lactobacillus salivarius UCC118 produces the broad spectrum class II 
bacteriocin, Abp118, which can protect against L.monocytogenesinfection in a mouse model[97].  
Mutant strains unable to produce Abp118 were incapable of stopping aL.monocytogenesinfection 
in mice. Strains of L.monoctyogeneswith an immunity gene for Abp118 were still able to cause an 
infection despite administration of L.salivarius UCC118 . Production of bacteriocins appears to 
play a role in aiding bacteria to carve out a niche in an intensely colonized environment such as 
the gastrointestinal tract [96].  In weaned pigs fed a probiotic mixture of L.murinus DPC6002, L. 
murinus DPC6003, L.pentosus DPC6004, L.salivarius DPC6005, and Pediococcuspentosaceus 
DPC6006, the strain producing a bacteriocin, L.salivariusDPC6005 was found in the highest 
amounts in ileum digesta and bound to the ileal mucosa[98].  Modification of Streptococcus 
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mutans to produce higher levels of bacteriocin allowed this strain to survive in the oral cavity for 
up to fourteen years with only a single application [96, 99, 100].  It is also possible that 
bacteriocins may act as signaling peptides in Gram-positive bacteria when concentrations are low, 
while acting in an inhibitory manner at high concentrations [101].  Additionally certain 
bacteriocins may also act as signaling peptides in an interspecies manner as well as cross-
kingdom by communication with the host [96].   
 
N-acyl Homoserine Lactone Hydrolases 
Lactobacilli may alsohave the ability to degrade N-acyl homoserine lactones, a class of Gram-
negative quorum sensing molecules involved in the induction of virulence factors in 
certainpathogenic bacteria.Bacillus spp. have shown the ability to degrade these signaling 
molecules through the expression of a N-acyl homoserine lactone hydrolase and inhibit the 
growth of Gram-negative plant pathogens [102, 103].Bacillus spp. N-acyl homoserine lactone 
hydrolases are classified as metallo-β-lactamases and contain the conserved motif HXHXDH and 
a zinc-binding motif [104].  Bacillus strain AI96 which was isolated from pond sediment was 
found to express aiiA, a gene encoding for an N-acyl homoserine lactone hydrolase.  When used 
as an aquatic food additive in zebrafish tanks it was found to attenuate the virulence of 
Aeromonashydrophila, a Gram-negative pathogen[105].  L.plantarumhas shown the capacity to 
inhibit the activity of N-acyl homoserine lactones produced by Pseudomonas aeruginosaand 
improve the healing process of burn wounds in mice with P. aeruginosa infections[106].  The 
ability of lactobacilli to produce N-acyl homoserinelactonases could be a key to the probiotic 
quality of pathogen inhibition which has been noted.   
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Adhesins: Mucin-binding &Fibronectin-binding Proteins 
Adhesion to the gastrointestinal mucosal layer is an important trait of lactobacilli that facilitates 
probiosisbyincreasingthe time of persistence in the gut, pathogen exclusion, and interactions with 
the host that may modulate the immune response [2, 107].  Adherence to the gastrointestinal tract 
is a complex process and involves multiple factors.  There are many proposed mechanisms for 
adhesion to the gastrointestinal tract mucosa,such as those instigated bysortase-dependent 
proteins, mannose-specific adhesins, extracellular matrix-binding proteins, mucus/mucin-binding 
proteins, and proteins with moonlighting functions such as elongation factor Tu, glyceraldehyde-
3-phosphate dehydrogenase, and heat shock protein GroEL[2].  The two proteins that will be 
focused on in this paper arefibronectin-binding proteinsand proteins that potentially bind to the 
mucus layer of the gastrointestinal tract. 
Intestinal epithelium is covered by a protective mucus layer comprised of a complex mixture of 
glycoproteins, antimicrobial compounds, immunoglobulins, lipids, and electrolytes.The thickness 
of this layer varies throughout the gastrointestinal tract; it is thickest in the colon and rectum.  
There are two layers, aloose outer layer that can easily be removed and an inner layer that is 
firmly attached to the underlying epithelium[108].  The presence of bacteria has been shown to be 
restricted to the outer layer[109].  Production of mucus-binding proteins in lactobacilli plays an 
important role in adhesion to the mucus layer and colonization of the intestinal tract.Mucus-
binding proteins are cell surface proteins with a typical signal peptide and aLPxTG anchoring 
motif in the C terminus for covalent attachment to the cell surface[108].  Mucins are large 
glycoproteins that constitute a major component of the mucus layer.An in silico study found that 
9Lactobacillus species harbored 48 proteins with mucus-binding domains[110].  The size of the 
protein and number of repeats varied greatly and were most common in, but not exclusive to 
bacteria that reside in the gastrointestinal tract.   
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Mucus-binding proteins that were able to bind pig gastric mucin as well as hen intestinal mucus 
have been described in L.reuteri1063 [111]. L.fermentum BCS87 expressed both mucus-binding 
and mucin-binding proteins and was able to bind pig mucus as well as partially purified pig 
gastric mucin[112]. L.plantarumWCFS1 was found to produce a mannose-specific adhesin, and 
when the gene encoding for this protein was inactivatedthe result was a mutant that was no longer 
able to agglutinate the yeast Saccharomyces cerevisiae, whose cell wall contains mannose 
[113].A study done on aL.salivarus UCC118 mutant deficient in a sortase-dependent mucus-
binding protein,revealed that the strain had a significantly decreased ability to adhere to Caco-2 
cells [114].L. rhamnosusis able to produce a mucus-binding pili as well as a mucus-specific 
adhesin that may work together synergistically in binding to the mucus layer [115].In a study 
conducted by Buck et al., severalL. acidophilus NCFM mutants deficient in genes associated with 
adherence were created[116]. A mutant deficient in a mucin-binding gene showed a 65% 
decrease in ability to bind to Caco-2 cells and a fibronectin-binding protein mutant showed a 
decrease of 76%.No single mutant became unable to bind to the cell line implying that adhesion 
to gastrointestinal epithelium is complex and multigenic[116]. 
Fibronectin is an adhesive glycoprotein and a major component of the extracellular matrix in 
vertebrates.Fibronectin plays important roles in cell adhesion, migration, growth and 
differentiation[117].  Fibronectin binding has been connected to the ability of pathogens such as 
Streptococcus pyogenesto cause infection[118].  Fibronectin as well as other extracellular matrix 
components such as fibrinogen and collagen are shed into the mucus layer or may be exposed if 
there is tissue damage.  It is possible that the ability of lactobacilli to bind extracellular matrix 
components may provide protection from pathogens in the event of tissue injury[119].In a survey 
of nineteen strains of Lactobacillus used in fermented dairy products all were able to bind 
fibronectin, as well as fibrinogen and collagen[119].  L. acidophilus and Lactobacillus agiliswere 
both found to bind the fibronectin of human intestinal 407 cells [120].  L. acidophilus CRL 639 
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bound fibronectin that was immobilized but not soluble forms, in addition this strain was able to 
bind immobilized collagen[120].  
 
Mercury Resistance 
The ability to survive in the presence of heavy metals and to protect their host from the toxic 
effects of heavy metals is not traditionally considered in probiotic studies, but will be touched 
upon briefly here due to the planned use of the probiotic strains being developed in animals 
experimentally exposed to mercury.  Heavy metal exposure has been associated with a wide 
variety of diseases and lactobacilli may offer protection from heavy metals. Certain strains of 
lactobacilli are able to bind heavy metals and may prevent them from entering the hosts system 
via the gastrointestinal tract[121].  L.reuteristrains isolated from mud and sludge were able to 
bind cadmium and lead and to remove these heavy metals from growth media.  These strains also 
demonstrated the ability to tolerate bile and acidic conditions as well as adhere to mucus[122].  
Lactobacilli have been shown to bind a wide variety of heavy metals[123-125].  In a test of 103 
lactic acid bacteria most strains were able to bind cadmium, lead, arsenic and mercury[126].  The 
amount of mercury removed from media was so high that the growth of the bacteria was 
hindered; possibly indicating that mercury was being taken into the cell.  A potential cell surface 
protein involved in mercury binding was also described.In vitro experiments done with HT29 
cells have shown that certain Lactobacillusstrains can reduce oxidative stress induced by heavy 
metals while otherstrains of this genus can be a source of oxidative stress[127].  In a mouse 
modelL.plantarumCCFM8610 reduced absorption of cadmium from the intestinal tract, reduced 
tissue accumulation of cadmium, and reduced oxidative tissue damage[128]. 
In summary, the mechanisms by which lactobacilli and other probiotic bacteria provide health 
benefits to their hostsare multiple and multifaceted, involvingthe interplay of a wide range of 
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genes and molecules.  It is clear that probiotic characteristics are strain dependent and in order to 
understand the probiotic characteristics of a specific strain it must be analyzed on a molecular 
level.  Following the annotation of the genomes sequenced in this study, putative homologues of 
the genes and gene families discussed above were identified by comparison to closely related 
genes found in the NCBI data bases in order to assess their putative functions and potential to 
impart probiotic characteristics.   
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CHAPTER III 
 
 
MATERIALS AND METHODS 
 
Bacterial Strains and Culture Conditions  
Thirty Lactobacillus strains were previously isolated from the intestine of Microtusochrogaster, 
the prairie vole, using enrichment by growth on Difco Lactobacilli MRS (de Mann, Rogosa and 
Sharpe medium for lactobacilli; BD Diagnostics, Franklin Lakes, NJ) at 37°C for 48 h within a 
GasPakTM 100 container and EZ Anaerobe Pouch system (BD Diagnostics) to generate anaerobic 
conditions (Assefa et al., in preparation).  The strains were assessed in vitro for probiotic 
characteristics and phylogenetic relationships (based on 16S rRNAgene sequences) to known 
probiotics (Assefa et al., in preparation). For this study, three strains, PV012, PV021,and 
PV034,were selected for genome sequencing based on the results of these in vitro tests.The 
strains were cultured from frozen stocks and grown at 37⁰C on agar plates with Difco Lactobacilli 
MRS (de Mann, Rogosa and Sharpe medium for lactobacilli; BD Diagnostics, Franklin Lakes, 
NJ).  Individual colonies were then selected and subcultured in Difco Lactobacilli MRS broth and 
incubated at 37⁰C for approximately 48 hours without shaking.   
 
DNA Extraction 
DNA was extracted using the following phenol chloroform method.  The cultures were spun 
down for 10 minutes at 4,500xg and the MRS broth was removed.  The cells were then
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resuspended in TE (10mM Tris; 1 mM EDTA, pH 8.0) and transferred to a clean tube.  Lysozyme 
was added and the cells were incubated for 30 min at 37°C.  Proteinase K and 10% SDS were 
added and the cells were incubated up to 3 hours.  One tenth volume of 5M NaCl was added and 
a phenol chloroform extraction was performed three times.  Isopropanol (1:1 vol.) was used to 
precipitate the DNA which was then washed with cold 70% ethanol.  The DNA was resuspended 
in TE containing RNase (15mM Tris-HCl, pH 8.0, 10mM EDTA; 100μg/ml RNAse;Teknova, 
Cat. Nr. T4579) and an additionalphenol chloroform extraction was performed.  One tenth 
volume 3 M Na-Acetate and 2.5 volumes ethanol were used to precipitate the DNA.  After 
centrifugation, the DNA pellets were washed with 70% ethanol, air dried and 
subsequentlyresuspended in 200µL of 10 mMTris pH 7.5.  DNA concentrations were determined 
using aQubit® fluorometer (Catalog no. Q32866, Invitrogen, Carlsbad, CA) in conjunction with 
the Qubit® dsDNA BR Assay Kit (Q32850, Invitrogen) according to the manufacturer’s protocol 
for determining the concentration of double stranded DNA.  Due to the fact that the extractions 
produced variable levels of DNA concentration and quality, additional DNA was extracted using 
the ZR Fungal/Bacterial DNA Mini Prep kit (Zymo Research, Irvine, CA) according to the 
manufacturer’s protocol. 
Library Building and Sequencing 
Isolated genomic DNA was fragmented to an approximate length of either 200 or 400 base pairs 
(depending on the sequencing protocol used) using the DiagenodeBioRuptor® sonicator 
(Diagenode, Denville, NJ). The settings used for the sonicator were chosen as described in the Ion 
Xpress™ Plus gDNA Fragment Library User Guide (Publication Part Number 4471989, Life 
Technologies, Grand Island, NY) under the section “Fragment gDNA with the BioRuptor® 
Sonication.”For the 200 base pair libraries, the samples were sonicatedfornine 10minute periods, 
for a total of 90 minutes with rest periods of 10 minutes between sonications.  For the 400 base 
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pair library, samples were sonicated for four 10 minute intervals and one 4 minute interval, for 
atotal of 24 minutes, without rest periods. 
Ion Torrent adapters were ligated to the DNA fragments and the nicks were repaired using the Ion 
Plus Fragment Library Kit according to the protocol in the Ion Xpress™ Plus gDNA Fragment 
Library User Guide (Publication Part Number 4471989) under the section “Ligate adapters, nick-
repair, and purify the ligated DNA.”  Fragments approximately 330 base pairs in length were 
selected for the 200 base pair library and fragments 480 base pairs were selected for the 400 base 
pair library, using Life Technologies E-Gel®SizeSelect™Agarose Gels according to the 
guidelines under the section “Size-select the library with the E-Gel® SizeSelect™Agarose Gel” 
(Publication Part Number 4471989).  To determine the proper dilution factor for emulsion PCR, 
real time PCR was performed using the Ion Library Quantitation Kitfollowing the protocol in the 
user guide (Publication Part Number 4468986 Rev. C).  The samples were then diluted and 
emulsion PCR was performed using the Ion PGM™ Template OT2 200 Kit V2 or the Ion 
PGM™ Template OT2 400 Kit, according to the protocol in the accompanying user guide (Ion 
Torrent Publication Number 4478372).  After emulsion PCR, the percent of templatedion sphere 
particles (ISPs) was measured using the Qubitflourometer with the Ion Sphere Quality Control 
Kit according to the protocol (Ion Torrent Publication Part Number 4478372).The samples were 
then sequenced using the Ion PGM™ Sequencing 200 Kit v2 or the Ion PGM™ Sequencing 400 
Kit according to the protocol in the section “Sequencing protocol—Ion 314™ Chip” (Ion Torrent 
Publication Number MAN0007273).  The Ion Torrent PGM 3.4.1 and 3.4.2 platforms were 
utilized with the 314 chip.  On the Ion Torrent Server, the Whole Genome setting was utilized 
with default settings. 
Bioinformatics 
Sequences were assembled both with reference genomes and de novo using the Ion Torrent 
MIRA assembler plug-in (v3.4.1.1 and v3.4.2.0) available on the Ion Torrent Server.  
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Additionally, all three genomes were also aligned to known Lactobacillus genomes using the Ion 
Torrent alignment plug-in (v3.4.48996).  Assembled sequences were then uploaded toRAST for 
annotation[17, 129].  PSI-BLAST was used to query the NCBI database[130] for proteins of 
similar function. The amino acid sequences were also queried through the NCBI Conserved 
Domain Database[131-133].  Amino acid sequences of the genes of interest were also compared 
to one another using CLUSTAL[134]. 
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CHAPTER IV 
 
 
RESULTS 
The genomes of PV012 and PV021 were sequenced using a 200 base pair read length sequencing 
kit (Ion PGM™ Sequencing 200 Kit v2) and the genome of PV034 was sequenced using a 400 
base pair read length kit (Ion PGM™ Sequencing 400 Kit).  With an average of 268 base 
pairs,the average read lengths from the 400 base pair kit were much shorter than expected.  The 
read length, however, was long enough to increase the length of the contigs after assembly (see 
Table 1). All three genomes aligned poorly with published lactobacilli whole genomes and de 
novo assembly produced the best assemblies.  
Table 1:  Sequencing and assembly summary 
Sequencing and Assembly Summary 
Strain PV021 PV012 PV034 
Sequencing kit 200 bp 200 bp 400 bp 
Average read length 213 178 286 
Viable reads 502,739 432,448 466,717 
Assembled reads 465,498 391,484 426,433 
Contigs 162 38 39 
Longest contig 214,706 235,324 380,249 
N50a) 51,611 183,313 216,286  
N90b) 3,732 44,233 24,772 
N95c) 1,993 11,827 13,120 
Coveraged) 65.64X 49.00X 97.12X 
Genome length 1,717,565 bp 1,549,227 bp 1,590,902 bp 
a) N50 is a weighted statistical measure of the median contig length in a set of sequences. 
The N50 value is the length L (in base pairs) such that 50% of the bases are in contigs the 
size ofL or greater. Larger N50 values correlate to more complete assemblies. 
b) N90: 90% of assembled reads are this length or greater. 
c) N95: 95% of assembled reads are this length or greater. 
d) The average coverage per base considering only contigs that are at least 5kb in length. 
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Lactobacillus PV021 sequencing overview: 200 bp kit 
Qubit quality control estimated 58.12% of Ion Sphere Particles (ISPs) weretemplatedprior to 
enrichment.  Sequencing produced a total of 1,024,696 reads, 47% of which were filtered due to 
polyclonality, 4% were filtered due to low quality and less than 1% of reads were filtered due to 
primer dimers resulting in a total of 502,739 viable reads.  The average read length produced was 
213 base pairs and the longest read produced was 372 base pairs (Fig. 1).   
 
 
Fig. 1:  Strain PV021 read length histogram  
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Strain PV021 assembly with MIRA and annotation with RAST 
De novo assembly with MIRA yielded the highestnumber of contigs in all strains sequenced.  
Assembly of strain PV021 with MIRA produced 162 contigs with the largest being 214,706 base 
pairs long.  A total of 465,498 reads were assembled with 65.64X coverage (Table 1).RAST 
discovered 220 subsystems, 1,658 protein coding sequences, 74 RNAs and 39 potential missing 
genes for strain PV021.  The genome size was 1,717,565 base pairs and60% of the genes 
identified by RAST were allocated to subsystems shown in Figure 2 and Table2. The closest 
relatives determined by RAST were firstL. johnsoniiNC533 and secondL. gasseriATCC 33323 
(Fig. 7). 
 
Fig. 2:  PV021 distribution of genes into subsystems   
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Lactobacillusstrain PV012 sequencing overview: 200 bp kit 
Qubit quality control estimated 52.88% of ISPs were templated prior to enrichment.  Sequencing 
produced a total of 916,599 reads, 46% of which were filtered due to polyclonality, 7% were 
filtered due to low quality and less than 1% of reads were filtered due to primer dimers resulting 
in 432,448 viable reads.  The average read length produced was 178 base pairs and the longest 
read produced was 367 base pairs (Fig. 3).   
 
Fig. 3:  Strain PV012 read length histogram 
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Strain PV012 assembly with MIRA and annotation with RAST 
Assembly of sequence data for strain PV012 with MIRA produced 38 contigs with the largest 
being 235,324 base pairs long.  A total of 391,484 reads were assembled with 49.00X coverage 
(Table 1).In strain PV012 RAST discovered a total of 214 subsystems, with 1,486 protein coding 
sequences, 101 RNAs and 16 potentially missing genes.  The genome sizewas 1,549,227 base 
pairs and 57% of the features discovered using RAST were allocated to the subsystemsshown in 
Figure 4 andTable 2.  The closest relatives determined by RAST were firstL. johnsoniiNC533 and 
secondL. gasseriATCC 33323 (Fig. 7). 
 
Fig. 4:  Distribution of genes into subsystems for PV021  
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Strain PV034 sequencing overview: 400bp kit 
Strain PV034 had a Qubit quality control estimation of 24.50% templated ISPs prior to 
enrichment.  Sequencing produced a total of 1,017,403 reads, 45% of which were filtered due to 
polyclonality, 9% were filtered due to low quality and less than 1% of reads were filtered due to 
primer dimers resulting in 466,717 viable reads.  The average read length produced was 286 base 
pairs and the longest read produced was 635 base pairs (Fig 5). 
 
Fig. 5:  Strain PV034 read length histogram 
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Strain PV034 assembly with MIRA and annotation with RAST 
Assembly of sequence data for strain PV034 with MIRA produced 39 contigs with the largest 
being 380,249 base pairs long.  A total of 426,433 reads were assembled with 97.12X coverage 
(Table 1).In strain PV034 RAST discovered a total of 227 subsystems,1,531 protein coding 
sequences, 68 RNAs and 22 potentially missing genes.  The genome size was 1,590,902 base 
pairs and 59% of the features discovered using RAST were allocated to the subsystems shown in 
Figure 6 andTable 2.  The closest relatives determined by RAST were firstL. gasseriATCC 33323 
and secondL. johnsoniiNCC 533 (Fig. 7). 
 
Fig. 6:  Distribution of genes into subsystems for PV034  
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Table 2. RAST gene allocation to subsystems in genome sequences of strains PV021, PV012, and 
PV034 
Subsystems assigned by RAST 
Number of features 
PV021 PV012 PV034 
Cofactors, Vitamins, Prosthetic Groups, Pigments  30 32 34 
Cell Wall and Capsule 96 88 74 
Virulence, Disease and Defense 28 28 33 
Potassium metabolism  4 5 4 
Photosynthesis  0 0 0 
Phages, Prophages, Transposable elements, Plasmids  8 0 10 
Membrane Transport  33 34 39 
Iron acquisition and metabolism 0 0 0 
RNA Metabolism  46 46 45 
Nucleosides and Nucleotides  29 29 26 
Protein Metabolism  167 167 171 
Cell Division and Cell Cycle  33 30 23 
Motility and Chemotaxis  0 0 0 
Regulation and Cell signaling 21 18 20 
Secondary Metabolism 1 1 1 
DNA Metabolism 103 92 102 
Regulons 0 0 0 
Fatty Acids, Lipids, and Isoprenoids 37 37 40 
Nitrogen Metabolism 0 0 0 
Dormancy and Sporulation 5 5 5 
Respiration 2 2 13 
Stress Response 21 20 24 
Metabolism of Aromatic Compounds  0 0 2 
Amino Acids and Derivatives 46 46 41 
Sulfur Metabolism  3 5 4 
Phosphorus Metabolism 15 15 15 
Carbohydrates  99 100 77 
Miscellaneous  8 8 11 
Total 835 808 814 
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Fig. 7:  Phylogenetic tree created using CLUSTAL with16SrRNA genes 
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Genes conferring potential probiotic functions discovered via RAST 
Aligning the genomes of all three strains with published genomes of other Lactobacillus spp. 
produced only low levels of alignment (all under 30%).  OverallPSI-BLAST protein queries 
resulted in matches with similar proteins identified in Lactobacillus spp.  When compared to one 
another using CLUSTAL, amino acid sequences from strains PV012 and PV021 shared a greater 
identity with one another than with PV034 (Table 3).  Many genes were found in all three strains 
while in some instances the genome of PV034 did not contain some of the potentially beneficial 
genes present in the PV021 and PV012 genomes.  For example, asecond heavy metal ATPase 
was lacking in PV034.  Additionally, the genome of PV034 only contained a single bacteriocin 
gene.  The amino acid sequences of proteins with mucin-binding domains in strain PV034 were 
significantly different from those found in PV021 and PV012.  The only strain without phage 
elements detected by RAST was strain PV012.  
 
D-Alanylation of Lipotechoic Acids 
The genes of the dltABCD operon as well as the DltR gene, the two component response regulator 
associated with the dltABCDoperon, were indentified in all three genomes by RAST.  The 
number of genes within theoperon varied between strains, however all operons shared the same 
conserved domains (Fig. 8a, 8b, 8c).  In strains PV021 and PV012the dltAgene encoded for a 
protein 507 amino acids in length and in PV034 the dltAgene encoded for 504 amino acids in 
length.For all three strains a PSI-BLAST search revealed that all three amino acids sequences 
shared an identity of 74% with aD-alanine--poly(phosphoribitol) ligase identified inL. crispatus.  
A query of the NCBI Conserved Domain Database resulted in a specific hit for a D-alanine:D-
alanyl carrier protein ligasedomain for all three strains.The dltBgene encoded for a protein 406 
amino acids in length in all three strains.  In strains PV021 and PV012, the amino acids sequence 
 40 
 
of this protein shared 81% identity with a D-alanyl transfer protein described inL. johnsonii.  In 
strain PV034, the amino acid sequence shared 83% identity with the same protein.A query of the 
NCBI Conserved Domain Database resulted in a specific hit fora D-alanyl-lipoteichoic acid 
biosynthesis protein, DltB.  DltCencoded for a protein 80 amino acids in length in all three 
strains.  In PV021 and PV012a PSI-BLAST query revealed a shared identity of 75%with a D-
alanine--poly(phosphoribitol) ligase identified inLactobacillus hominisand a shared identity of 
90% with the same protein for PV034.  A conserved domain for D-alanine--poly(phosphoribitol) 
ligase subunit 2 was discovered in all three strains. DltDwas identified as two separate genes in 
strain PV021 by RAST, the first of which encoded for a protein 101 amino acids in length that 
shared a 77% homology with aD-alanyl transfer protein describedL. gasseri and a query of the 
amino acids resulted in specific hit for DltD N-terminal region domain.  The second dltDgene 
identified in strain PV021 encoded a protein647 amino acids in length which shared 66% identity 
with a D-alanyl transfer protein described inL. gasseri.  The conserveddomain hits include a 
specific hit for aDltD C-terminal region, a specific hit for a beta-lactamase domainand a non-
specific hit for aDltD central region (Fig 8a).  In strain PV012, the dltDwas reported as a single 
gene encoding for 755 amino acids that shared 70% identity with a D-alanyl transfer protein 
described inL. gasseri.  The conserved domains identified were the same as those found in the 
two individual genes identified in PV021(Fig. 8b).  In strain PV034,onedltDgene was found that 
encoded for a protein 429 amino acids in length that shared 72% identity with a D-alanyl carrier 
protein described inL. gasseri. A gene containing the same beta-lactamase domain followed the 
dltDgene, this section of sequence data was considered to be part of the dltDgene in both of the 
other genomes.  This gene encoded for a protein 294 amino acids in length that shared 35% 
identity with a serine-type D-Ala-D-Alacarboxypeptidase protein described inL. plantarum.  
Again the same conserved protein domains were found in both genes(Fig 8c). It is likely that an 
assembly or annotation error occurred in the dltDgene for strain PV012 and PV021 as the most 
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common arrangement of conserved domains for the dltD protein seen in the NCBI data base is 
similar to the arrangement in PV034. 
The dltRgene associated with regulation of dltABCD and the regulation of D-alanyl-lipoteichoic 
acid biosynthesis, sensor-histidine kinase genes were present in all three genomes.  The dltRgene 
encoded for a protein 222 amino acids in length in all three genomes.  A PSI-BLAST query 
resulted in a matched identity of 56% in PV021, 57% in PV012 and 40% in PV034 with a protein 
involved in regulation of D-alanyl-lipoteichoic acid biosynthesis identified in Lactobacillus 
sucicola JCM 15457.  In all three amino acids sequences, a specific hit for a signal receiver and a 
transcriptional regulatory protein with DNA binding sites were revealed in a conserved domain 
query.  The genesensor histidine-kinase gene encoded for a protein 428 amino acids long in 
PV021 and PV012, which shared an identity of 61% with a signal transduction histidine kinase 
identified in L. gasseri.  In PV034 this gene encoded for a protein 425 amino acids long that 
shared an identity of 56% with a signal transduction histidine kinase identified inL. gasseri .  All 
three amino acids sequences contained specific hits for histidine kinase A and histidine kinase-
like ATPase conserved domains. 
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Fig. 8a:  PV021Dltoperon arrangement in RAST 
 
Fig. 8b:  PV012Dltoperon arrangement in RAST 
 
Fig. 8c:  PV034Dltoperon arrangement in RAST 
Fig. 8:  Arrangement of the dltABCDoperon and location of conserved domains.  The schematic 
depicts dltABCD operon structure and conserved protein domains in strains PV021 (a), PV012 
(b), and PV034 (c): D-alanine:D-alanyl carrier protein ligase subunit 1(DltA), D-alanyl-
lipoteichoic acid biosynthesis protein (DltB), D-alanine--poly(phosphoribitol) ligase subunit 2 
(DltC), DltD N-terminal region domain (DltD_N),  DltD central region (DltD_M) a DltD C-
terminal region (DltD_C) a beta-lactamase domain (β-lac.)  
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Bile resistance 
All three genomes contained a gene encoding for a choloylglycine hydrolase.  The protein 
was326 amino acids in length and shared a 60% identity with a choloylglycine hydrolase 
described inL. reuteri.  Query of the NCBI Conserved Domain Database resulted in a specific hit 
for a conjugated bile salt acid hydrolase (CBAH) for all three amino acid sequences.  All three 
genomes were also found to have several multidrug transporters.  RAST discovered two 
multidrug-efflux transporters of the major facilitator superfamily in PV021 and PV012 as well as 
a single ABC-type multidrug transport system, a singlepermease of the drug/metabolite 
transporter (DMT) superfamily and one nonspecific multidrug transporter.  The genome of strain 
PV034 contained one ABC-type multidrug transport system, two genes for a permease of the 
drug/metabolite transporter (DMT) superfamily and one nonspecific multidrug transporter.  It is 
not known if these transporters play a role in bile resistance but theyare mentioned here because 
multidrug transporters have been associated with bile resistance.  
 
Bacteriocins 
RAST discovered a total of five genes encoding forthe bacterocinhelveticinin the genome of 
strain PV012, four of which were identical to genes found in strain PV021.  In strain PV012, four 
of the five genes were arranged within close proximity to one another (Fig 9), while in strain 
PV021 only two were near one another.  In PV021 many ofthe genes encoding for 
bacterocinswhere found near the end of contigs.Of the genes encoding bacterocins in PV021 and 
PV012, the geneencoding for a protein of342 amino acids in length, shared 46% identity with a 
bacteriocin identified inL. helveticus. The gene encoding for a protein of 65 amino acids in length 
shared 56% of identity with a bacteriocin identified inL. helveticus. The gene encoding for a 
protein of 326 amino acids in length shared a 65% identity with bacteriocinhelveticin-J identified 
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inL. helveticusand the gene encoding for a protein of 328 amino acids in length shared65% 
identity with bacteriocinhelveticin-J  identified inLactobacillus amylolyticus.  The gene encoding 
for a protein of 38 amino acids in length, which was only found in strain PV012 shared 63% 
identity with a bacterocin identified inL. helveticus.  Only one gene encoding for a bacteriocin 
was discovered by RAST in the genome of strain PV034.  It encoded for a protein 324 amino 
acids in length that shared a 54% identity withbacteriocinhelveticin-J from L. hominis.No 
conserved domains were identified. 
 
Fig. 9:  Schematic of bacterocin genes found in proximity to one another in PV012 
 
N-acyl homoserine lactone hydrolase 
RAST identified a gene encoding a putative N-acyl homoserine lactone hydrolase in PV021 and 
PV012 that encoded for a protein 283 amino acids in length.  In PV021 and PV012, the gene 
encoded for an amino acids sequence which shared an identity of 67%  and 65% respectively, 
with a metallo-beta-lactamase identifiedL. gasseri and in PV012 the amino acids sequence shared 
a 65% identity with the same protein.  A conserved domain query resulted in a specific hit for the 
metallo-beta-lactamase superfamilydomain and a nonspecific hit for a Zn-dependent hydrolase.  
No N-acyl homoserine lactone hydrolase was identified in strain PV034 although a gene 
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identified as a hypothetical protein shared 87% to 88% identity with the N-acyl homoserine 
lactone hyrolase in the other two genomes. A query of conserved domains resulted in a specific 
hit for a metallo-beta-lactamase superfamily but no nonspecific hits for Zn-dependent hydrolase 
for the amino acid sequence of the hypothetical protein in strain PV034. 
 
Adhesins: Mucin-binding & fibronectin-binding proteins 
Several potential mucin-binding proteins were identified in all three genomes.  In strains PV021 
and PV012 RAST identified a gene encoding for a hypothetical protein 1663 amino acids in 
length.  In both instances the gene was located alone on a single contig.  Both amino acids 
sequences shared a 31% identity with an adhesin described inL. gasseri.  The conserved domains 
included five specific hits formucin-binding domains and a non-specific hit for a Rib/alpha-like 
repeat domain (Fig. 10a).  In strain PV021 RAST also identified a gene encoding for a protein 
1117 amino acids in lengththat shared 32% identity with an adhesin described inL. gasseri.  
Conserved domains included a specific hit for mucin-binding domain, a Gram-positive anchor 
and rib/alpha-like repeat (Fig. 10b).  A similar gene was identified for strain PV012 that encoded 
for a protein 692 amino acids in length that shared a 32% identity with an adhesin identified in L. 
gasseri.  Again the conserved domains located include amucin-binding domain, a Gram-positive 
anchor and a rib/alpha-like repeat (Fig. 10c).  In strain PV034 RAST identified a gene encoding 
for a protein 229 amino acids in length that shared a 33% identity with a mucus binding protein 
identified in L. hominis.  The conserved domain hits included a specific hit for a mucin-binding 
domain and a Gram-positive anchor (Fig. 10d).  Another gene identified in strain PV034 encoded 
for a protein 1381 amino acids in length that shared a 26% identity with a mucus binding domain 
described in L. johnsonii. Conserved domains revealed included a specific hit for a mucin-binding 
domain and Gram-positive signal peptide in the YSIRK family (Fig. 10e). 
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In strain PV021 RAST identified a gene which encoded for fibronectin-binding protein which 
was 564 amino acids in length and shared a 69% identity with a putative fibronectin-binding 
protein identified in Lactobacillus delbrueckii subsp. lactis.  The conserved domain hits included 
a specific hit for a domain of unknown function (DUF814) which occurs in proteins that have 
been annotated as fibronectin or fibrinogen binding protein[135].  Additionally there was a multi-
domain hit for fibronectin-binding protein A.  In strain PV012 it appears that RAST split this 
sequence into two genes, the portion of the gene containing the DUF814 domain encoded for 139 
amino acids thatshared a 79% identity with a fibronectin-binding protein identified in L. 
gasseri.The portion of the gene resulting in the multi-domain hit for a fibronectin-binding A 
encoded for a protein 379 amino acids long and shared a 70% identity with a fibronectin-binding 
protein identified in L. gasseri.  Splitting of this gene may be due to a sequencing, assembly, or 
annotation error.In strain PV034 the putative fibronectin-binding protein gene encoded for a 
protein 564 amino acids in length which shared 80% identity with a fibronectin-binding protein 
identified in L. gasseri.  Both the multi-domain hits for fibronectin-binding and DUF814 were 
present.   
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Fig. 10a:  PV012 and PV021MucBPa 
 
Fig. 10b:  PV021MucBPb 
 
Fig. 10c:  PV012MucBPc 
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Fig. 10d:  PV034MucBPd 
 
Fig. 10e:  PV034MucBPe 
Fig. 10a-e:  Conserved domains identified in potential mucin-binding proteins by query of the NCBI Conserved Domain Database 
 
 49 
 
Mercury Resistance 
RAST identified a putative mercuric ion reductase gene which encoded for a protein 444 amino 
acids in length in all genomes.  According to PSI-BLAST results the amino acid sequence for the 
gene in strain PV021 shared 69% identity with a pyridine mercuric reductase described in L. 
helveticus.  In PV012 the amino acid sequence shared a 68%with the same pyridine mercuric 
reductase and for PV034 there was a 72% shared identity with the same protein.  In all three 
amino acid sequences, conserved domain hits included specific hits for a pyridine nucleotide-
disulphideoxidoreductase and a pyridine nucleotide-disulphideoxidoreductasedimerization 
domain.  A gene encoding for a lead, cadmium, zinc and mercury transporting ATPase was 
identified in all three genomes.  The gene encoded for a protein 618 amino acids long in PV021 
and PV012 and 629 amino acids long in PV034.  The amino acid sequences encoded by the genes 
in PV021 and PV012 shared an 83% identity with a metal ABC transporter ATPase described 
inL. reuteri.  Forstrain PV034 the amino acid sequence shared a 71% identity with a heavy metal 
translocating P-type ATPase described in Lactobacillus sp. ASF360.  Conserved domains in all 
three protein sequences include anE1-E2 ATPase domain and haloaciddehalogenase-like 
hydrolase domain.  Strains PV021 and PV012 had an additional gene for a lead, cadmium, zinc 
and mercury transporting ATPase identified by RAST which encoded for a protein 627 amino 
acids in length.  Both amino acid sequences shared a 73% identity with a heavy metal 
translocating P-type ATPase described inLactobacillus sp. ASF360 and contained specific hit for 
an E1-E2 ATPase domain and a predicted ATPase Soluble P-type ATPase domain, as well as a 
multi-domain hit for a zinc/cadmium/mercury/lead-transporting ATPase. 
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Table 3:  CLUSTAL comparison of amino acid sequences of genes of interest 
Gene PV012 : 
PV021 
PV012 : 
PV034 
PV021 : 
PV034 
DltA 99.60% 81.31% 80.91% 
DltB 99.75% 77.48% 77.04% 
DltC 100.00% 74.68% 74.68% 
DltD 99.87% 69.86% 70.09% 
DltR 93.67% 72.40% 69.23% 
Sensor histidine kinase (dltR) 98.83% 58.25% 57.78% 
Bile salt hydrolase 99.69% 89.54% 89.23% 
N-acyl homoserine lactone hydrolase 96.10% N/A N/A 
Bacterocinhelveticin  (326 aa) 98.17% 51.70% 52.01% 
Bacteriocinhelveticin  (65 aa) 100.00% N/A N/A 
Bacteriocinhelveticin  (342 aa) 100.00% N/A N/A 
Bacteriocinhelveticin  (326 aa) 100.00% N/A N/A 
Mercury reductase 99.32% 73.14% 73.14% 
Lead, cadmium, zinc mercury ATPase 
pump (a) 
99.84% 78.43% 78.59% 
Lead, cadmium, zinc mercury ATPase 
pump (b) 
98.70% N/A N/A 
Fibronectin binding protein 96.12% 72.29% 76.55% 
MucBPa 100.00% N/A N/A 
MucBPb : MucBPc 95.33% N/A N/A 
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CHAPTER V 
 
 
CONCLUSION 
 
Host adaptation is an important factor to consider in the selection of probiotic strains, and somany 
of the genes investigated in this study are involved in the ability to survive in the gastrointestinal 
tract.  Bacterial host adaptation can come about in many ways and may occur through large scale 
gene acquisitions or losses; change can also occur in more subtle ways such as the modification 
of individual genes or molecular pathways [136-138].  These evolutionary changes occur over 
time and shape bacteria so that they attain optimal fitness in a certain environment.  In a study 
conducted by Frese et. al. L. reuteriF275, a human derived strain, was unable to colonize the 
gastrointestinal tract of Lactobacillus-free mice; however, L. reuteri100-23, a mouse derived 
strain was able to colonize Lactobacillus-free mice[136].  A comparison of the two genomes 
revealed that L. reuteri100-23 contained 633 genes with noorthologs in strain F275.  The genes 
with designated functions unique to L. reuteri100-23 included: transport proteins, regulatory 
proteins, enzymes, glycosyltransferases, cell wall and membrane bound proteins, an auxiliary 
protein secretion system, and a urease gene cluster.  The only unique set of genes in L. 
reuteriF275 with an identified function were in a pdu-cbi-cob-hem cluster.  This gene cluster is 
involved in the production of coenzyme B12 [136].This study illustrates the significance of host 
adaptation and its importance when considering probiotic candidates.  How the gut microbiota 
forms is not fully understood, but there is evidence that host genetics play a role in shaping the 
composition of the gut microbiota [139].  The relationship between
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gut microbiota and the host is complex.  Theco-evolution of the microbiota and hostmay be the 
basis for the strain-specificresults seen in probiotics.  The genes involved in host adaptation 
described in this study were closely related to genes described in other Lactobacillus spp.,but they 
appeared to be more closely related to one another.  These three strains should be better able to 
colonize and produce a positive effect in the prairie vole animal model. 
Because lactobacilli tend to live in nutritionally rich environments such as the gastrointestinal 
tract some species have lost genes involved in the metabolism of certain nutrients.In fact 
Lactobacillus spp. are one of the few organisms that have no requirement for iron [140, 
141].Certain strains of Lactobacillus do appear to benefit from the presence of iron depending on 
the availability of particular nucleotides [140].  The ability to survive without the presence of iron 
give lactobacilli a competitive edge over pathogenic bacteria [142].  No genes involved in the 
acquisition and metabolism of iron were found in the three strains sequenced.  Strain PV034 was 
also the only strain in which RAST identified genes that were involved in the metabolism of 
aromatic compounds.  Additionally, no genes involved in nitrogen metabolism were found.  
Interestingly, RAST identified only two genes involved in respiration in the genomes of strains 
PV021 and PV012 while it identified thirteen genes involved in respiration in strain PV034.  
PV034 was the only strain able to produce hydrogen peroxide during the in vitro testing and the 
additional respiratory genes may be involved in this strain’s ability to do so.   
Bacteriophages, plasmids, and transposons are sources of genetic diversity in bacteria[143].  It 
has been proposed that prophages carry genes which are of selective benefit to their host in a 
specific ecological niche [144].  Certain bacteriophagescarry virulence factors and can integrate 
into a bacterium’s genome creating pathogenicity islands; often over time these phages lose the 
genes that allow them to become lysogenic again.  One such example is the diphtheria toxin 
which is carried by a bacteriophage that allows Corynebacteriumdiphtheriae,a common non-
pathogenic resident of the upper respiratory tract, to produce diphtheria toxin and cause disease.  
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Pathogenicity can make up as much as 10 to 20% of a bacterial genome[143].  No Lactobacillus 
phages have ever been reported to carry virulence genes.While little research exists on the 
relationship of phages and probiotics, in dairy fermentation, phage infection can have a 
deleterious effect leading to food spoilage [145].  When selecting probiotic candidate strains, 
those without prophages would likely be more desirable, because these strains would have more 
genetic consistency and would likely have a higher degree of fitness.  Of the three sequenced 
genomes in this study, RAST identified phage elements in strains PV021 and PV034.  Whether 
these phages can become lysogenic and what characteristics they impart remains to be 
determined.  Strain PV012 was the only strain without a phage, potentially making it a better 
probiotic candidate. 
While Lactobacillus spp. are generally recognized as safe (GRAS) and have only been associated 
with infection in severely immunocompromised individuals[146],genes homologous to ones that 
enable pathogenic bacteria to cause disease, have been found inthe genomes of lactobacilli.A 
study assessing the virulence ofLactobacillusstrains isolated from the fecal material of healthy 
adults, blood isolates from patients with bacteremia, and commerical probiotic strains found that 
the blood isolates showed a trend toward a higher ability to adhere to mucus than the probiotic 
strains or strains from fecal isolates (P=0.07)[147].  In addition, probiotic strains induced lower 
levels of respiratory bursts in peripheral blood mononucleocytes (P=0.05) and showed a trend 
toward lower sensitivity to human serum (P=0.07).  The condition of the patients from whom the 
blood isolates originated is not stated in this paper, but it is likely that these individuals were 
immunocompromised.  Adhesins in pathogenic bacteria contribute to their virulence, but in 
lactobacilli adhesion to mucus is thought of as a desirable quality and a mechanism by which 
lactobacilli compete with and exclude pathogens[22].  There are numerous studies which have 
tied the ability of lactobacilli to adhere to mucus with pathogen inhibition.Fibronectin-binding 
proteins have been identified in lactobacilli; however, their function is not understood.  
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Fibronectin-binding proteins have been shown to play a role in invasion of host cells by 
Streptococcus pyogenes[148].  Additionally, certain types of fibronectin-binding proteins allow S. 
pyogenesto evade phagocytosis by inactivating the complement pathway.A study which induced 
peptic ulcers in mice found that promotion of Lactobacillus colonization supported wound 
healing and lowered the presence of Gram-negative bacteria [149]. It is possible that ability of 
lactobacilli to bind extracellular matrix components and deter pathogens could contribute to the 
increased wound healing seen in this study.  While lactobacilli are generally considered safe the 
presence of potential virulence factors should be taken into consideration, especially in the case 
of immunocompromised persons.  
Another aspect to consider in the selection of probiotics is antibiotic resistance.  Many lactobacilli 
are resistant to a wide variety of antibiotics, but the most commonly reported antibiotic resistance 
genes aretet(M), which confers tetracycline resistance and erm(B), which confers erythromycin 
resistance.  The antibiotic resistance genes, described in lactobacilli, are in some cases mobile.A 
growing body of whole genome sequences has made assessment of antibiotic resistance genes 
easier[150]. Genes conferring potential antibiotic resistance were identified by RAST in all of the 
three genomes sequenced in this study.  It is not known if they are functional and which 
antibiotics they are effective against.  Antibiotic resistance is generally thought of as an 
undesirable characteristic of bacteria and in probiotics,but there could be circumstances in which 
antibiotic resistance in lactobacilli would make them more effective, such as cases of antibiotic-
induced diarrhea.   
Whether these three strains of Lactobacillus can be classified as an already known species or if 
they are a newly identified species must still be determined.The use of the 16S rRNA gene to 
classify bacteria has been the standard since discovered by Carl Woese and his colleagues in the 
1970s [151-153].Using the 16S rRNA gene to perform taxonomic classification can be 
problematic.  For instance Bacillus globisporus and Bacillus psychrophilus which share 99.8% 
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sequence identity when comparing 16S rRNA genes, but only a 23-50% identity when their entire 
genomes are compared using DNA-DNA hybridization[154].  One issue with using 16S rRNA 
for taxonomic classification is intra-genomic heterogeneity.  Bacteria often contain more than one 
copy of the 16S rRNA gene that are usually identical, but not always, which can lead to 
difficulties using 16S rRNA for classification[155].  Additionally, while it was originally thought 
that 16S rRNA genes did not participate in horizontal gene transfer events such events have been 
reported [155].   
RAST identified L. johnsoniiNC533 and L. gasseriATCC 33323 as the two most closely related 
bacteria to all three strains based on a comparison of universal protein families and/or large 
highly conserved protein families.  PV012 and PV021 were more closely related to L. 
johnsoniiNC533 and PV034 to L. gasseriATCC 33323.  Results were similar when comparing 
the 16SrRNA genes (Figure 7).  In this instance, the results arrived at using the 16S rRNA gene to 
classify these lactobacilli, were supported by the results from RAST’s comparison of conserved 
proteins.  The use of the 16S rRNA gene may have several disadvantages, but because it is so 
widely used and well documented that it is logical to continue to implement its use. One 
important  point made by Yarza et. al. is that only full 16S rRNA genes of good quality should be 
used[156].  The need for a well delineated set of thresholds for cultured and uncultured species 
such as the one devised by the author and his colleagues is also stressed. 
Next-generation sequencing platforms such as the Ion Torrent PGMTM, which was used in this 
study,have made it less expensive to sequence bacterial genomes.  Unfortunately read lengths are 
still too short, making it difficult to complete a bacterial genome sequence using next-generation 
sequencing alone.When assessing 454 GS Junior, MiSeq, and Ion Torrent PGMTM during the 
German E. coli O104:H4 outbreak none of the three bench top sequencers were able to produce a 
genome that could be assembled into one contig[14]. De novo genome assembly of second-
generation sequence data has been proven a difficult task for which there is no current 
 56 
 
computational solution [157].  Repetitive sequences are problematic when the read length is 
shorter than the repetitive region.One problems is that these repetitive reads can be collapsed 
together on top of one another, when they should be two separate sequence areas[158].  For 
strains PV012 and PV034 the number of contigsafter assembly was fairly low, but because of 
repetitive areas such as the rRNA operon the genomes were not closable.  Further assessment of 
genes identified by RAST may also be required, as the information in public data bases utilized 
by automated annotation pipelines such as RAST does contain errors and as a result genes may be 
annotated incorrectly [159].  In the genomes of the three strains sequenced for this study several 
genes were split into two when they were most likely single genes, whether these were truly 
errors and if the error was due to the annotation or to sequencing it not known.  Next-generation 
sequencing is a valuable tool that has lowered the price of sequencing and lead to a dramatic rise 
in the number of published genomes.  The need for longer read lengths is apparent, butfortunately 
the level of competition between leading manufacturers of next-generation platforms is high and 
new advances in technology are occurring rapidly.   
The genomes of all three Lactobacillus spp. isolated did contain genes which were similar to 
genes described prior studies on probiotic mechanisms.  Probiosis is a multifactorial processthat 
involves a large number of genes (known and unknown); for brevity’s sake only the genes of 
particular interest to this study were included.  These genes were chosen based on their relevance 
in the vole gastrointestinal tract and are only a small percentage of the genes identified by RAST.  
Many putative genes were identified by RAST for which the function is unknown.  Sequencing of 
a genome produces a vast amount of data that must be sifted through and organized to be useful.  
Fortunately there are many publically available tools with which to accomplish this task.  The 
sequencing of these three genomes will lay the foundation for future studies on the mechanisms 
of probiosis.  
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APPENDIX 
 
Table A1.  RAST Annotation Details 
Strain RAST feature identification  Contig Start Stop Feature Function 
PV012 fig|6666666.64077.peg.502 13 67812 69332 D-alanine--
poly(phosphoribitol) ligase 
subunit 1 (EC 6.1.1.13) 
PV012 fig|6666666.64077.peg.503 13 69329 70546 D-alanyl transfer protein DltB 
PV012 fig|6666666.64077.peg.504 13 70568 70807 D-alanine--
poly(phosphoribitol) ligase 
subunit 2 (EC 6.1.1.13) 
PV012 fig|6666666.64077.peg.505 13 70800 73064 Poly(glycerophosphate chain) 
D-alanine transfer protein 
DltD 
PV012 fig|6666666.64077.peg.856 3 56524 55241 Regulation of D-alanyl-
lipoteichoic acid biosynthesis, 
sensor histidine kinase 
PV012 fig|6666666.64077.peg.857 3 57199 56534 Regulation of D-alanyl-
lipoteichoic acid biosynthesis, 
DltR 
PV012 fig|6666666.64077.peg.844 3 41512 40535 Choloylglycine hydrolase 
(EC 3.5.1.24) 
PV012 fig|6666666.64077.peg.416 12 29259 30242 Bacteriocinhelveticin 
PV012 fig|6666666.64077.peg.1374 8 23129 24154 Bacteriocinhelveticin 
PV012 fig|6666666.64077.peg.1378 8 25992 26105 Bacteriocinhelveticin 
PV012 fig|6666666.64077.peg.1379 8 26069 26263 Bacteriocinhelveticin 
PV012 fig|6666666.64077.peg.1384 8 29638 30615 Bacteriocinhelveticin 
PV012 fig|6666666.64077.peg.88 10 21230 22078 N-acyl homoserine lactone 
hydrolase 
PV012 fig|6666666.64077.peg.790 21 403 5391 hypothetical protein 
PV012 fig|6666666.64077.peg.1263 6 136936 139011 hypothetical protein 
PV012 fig|6666666.64077.peg.168 10 95709 96845 Fibronectin-binding protein 
PV012 fig|6666666.64077.peg.169 10 96985 97401 Fibronectin-binding protein 
PV012 fig|6666666.64077.peg.115 10 50152 48821 Putative Dihydrolipoamide 
dehydrogenase (EC 1.8.1.4); 
Mercuric ion reductase (EC 
1.16.1.1); PF00070 family, 
FAD-dependent NAD(P)-
disulphideoxidoreductase 
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PV012 fig|6666666.64077.peg.469 13 37834 35981 Lead, cadmium, zinc and 
mercury transporting ATPase 
(EC 3.6.3.3) (EC 3.6.3.5); 
Copper-translocating P-type 
ATPase (EC 3.6.3.4) 
PV012 fig|6666666.64077.peg.498 13 65190 63310 Lead, cadmium, zinc and 
mercury transporting ATPase 
(EC 3.6.3.3) (EC 3.6.3.5); 
Copper-translocating P-type 
ATPase (EC 3.6.3.4) 
PV021 fig|6666666.64078.peg.459 15 9901 8381 D-alanine--
poly(phosphoribitol) ligase 
subunit 1 (EC 6.1.1.13) 
Strain RAST feature identification  Contig Start Stop Feature Function 
PV021 fig|6666666.64078.peg.458 15 8384 7167 D-alanyl transfer protein DltB 
PV021 fig|6666666.64078.peg.457 15 7145 6906 D-alanine--
poly(phosphoribitol) ligase 
subunit 2 (EC 6.1.1.13) 
PV021 fig|6666666.64078.peg.456 15 6913 6611 Poly(glycerophosphate chain) 
D-alanine transfer protein 
DltD 
PV021 fig|6666666.64078.peg.455 15 6591 4651 Poly(glycerophosphate chain) 
D-alanine transfer protein 
DltD 
PV021 fig|6666666.64078.peg.229 11 105141 104476 Regulation of D-alanyl-
lipoteichoic acid biosynthesis, 
DltR 
PV021 fig|6666666.64078.peg.228 11 104466 103183 Regulation of D-alanyl-
lipoteichoic acid biosynthesis, 
sensor histidine kinase 
PV021 fig|6666666.64078.peg.727 22 49663 48686 Choloylglycine hydrolase 
(EC 3.5.1.24) 
PV021 fig|6666666.64078.peg.582 19 1351 326 Bacteriocinhelveticin 
PV021 fig|6666666.64078.peg.659 20 16194 17177 Bacteriocinhelveticin 
PV021 fig|6666666.64078.peg.895 29 1387 1581 Bacteriocinhelveticin 
PV021 fig|6666666.64078.peg.901 29 4957 5934 Bacteriocinhelveticin 
PV021 fig|6666666.64078.peg.500 16 31774 30926 N-acyl homoserine lactone 
hydrolase 
PV021 fig|6666666.71045.peg.1246 55 5760 772 hypothetical protein 
PV021 fig|6666666.64078.peg.1045 4 61920 58570 hypothetical protein 
PV021 fig|6666666.64078.peg.315 12 11153 12844 Fibronectin-binding protein 
PV021 fig|6666666.64078.peg.471 16 2382 3713 Putative Dihydrolipoamide 
dehydrogenase (EC 1.8.1.4); 
Mercuric ion reductase (EC 
1.16.1.1); PF00070 family, 
FAD-dependent NAD(P)-
disulphideoxidoreductase 
PV021 fig|6666666.64078.peg.1304 73 280 771 Lead, cadmium, zinc and 
mercury transporting ATPase 
(EC 3.6.3.3) (EC 3.6.3.5); 
Copper-translocating P-type 
ATPase (EC 3.6.3.4) 
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PV021 fig|6666666.64078.peg.464 15 12521 14401 Lead, cadmium, zinc and 
mercury transporting ATPase 
(EC 3.6.3.3) (EC 3.6.3.5); 
Copper-translocating P-type 
ATPase (EC 3.6.3.4) 
PV034 fig|6666666.71150.peg.1099 4 14200 12689 D-alanine--
poly(phosphoribitol) ligase 
subunit 1 (EC 6.1.1.13) 
PV034 fig|6666666.71150.peg.1098 4 12692 11475 D-alanyl transfer protein DltB 
PV034 fig|6666666.71150.peg.1097 4 11415 11176 D-alanine--
poly(phosphoribitol) ligase 
subunit 2 (EC 6.1.1.13) 
Strain RAST feature identification  Contig Start Stop Feature Function 
PV034 fig|6666666.71150.peg.1096 4 11183 9897 Poly(glycerophosphate chain) 
D-alanine transfer protein 
DltD 
PV034 fig|6666666.71150.peg.1095 4 9778 8897 Beta-lactamase class C and 
other penicillin binding 
proteins 
PV034 fig|6666666.71150.peg.1006 3 297541 298205 Regulation of D-alanyl-
lipoteichoic acid biosynthesis, 
DltR 
PV034 fig|6666666.71150.peg.1007 3 298217 299491 Regulation of D-alanyl-
lipoteichoic acid biosynthesis, 
sensor histidine kinase 
PV034 fig|6666666.71150.peg.288 10 136075 135098 Choloylglycine hydrolase 
(EC 3.5.1.24) 
PV034 fig|6666666.71150.peg.195 10 36947 37918 Bacteriocinhelveticin J 
PV034 fig|6666666.71150.peg.20 1 27144 27830 Putative mucus binding 
protein 
PV034 fig|6666666.71150.peg.404 15 6750 7556 Adhesin of unknown 
specificity SdrC 
PV034 fig|6666666.71150.peg.425 16 19582 21273 Fibronectin-binding protein 
PV034 fig|6666666.71150.peg.11 1 18300 19631 Putative Dihydrolipoamide 
dehydrogenase (EC 1.8.1.4); 
Mercuric ion reductase (EC 
1.16.1.1); PF00070 family, 
FAD-dependent NAD(P)-
disulphideoxidoreductase 
PV034 fig|6666666.71150.peg.1103 4 16665 18551 Lead, cadmium, zinc and 
mercury transporting ATPase 
(EC 3.6.3.3) (EC 3.6.3.5); 
Copper-translocating P-type 
ATPase (EC 3.6.3.4) 
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